Skip Navigation



Brain Advance Access published online on June 24, 2008

Brain, doi:10.1093/brain/awn112
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
131/8/2094    most recent
awn112v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rowe, J. B.
Right arrow Articles by Owen, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rowe, J. B.
Right arrow Articles by Owen, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition

J. B. Rowe1,2,3, L. Hughes1,2, B. C. P. Ghosh1, D. Eckstein1,2, C. H. Williams-Gray1,4, S. Fallon2, R. A. Barker1,4 and A. M. Owen2,3

1University of Cambridge Department of Clinical Neurosciences, CB2 2QQ, 2Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, 3University of Cambridge Behavioural and Clinical Neurosciences Institute, CB2 3EB and 4Cambridge Centre for Brain Repair, CB2 OPY, UK

Correspondence to: Dr J. B. Rowe, MRC-CBU, 15 Chaucer Road, Cambridge, CB2 7EF, UK E-mail: james.rowe{at}mrc-cbu.cam.ac.uk

Cognitive deficits are very common in Parkinson's disease particularly for ‘executive functions’ associated with frontal cortico-striatal networks. Previous work has identified deficits in tasks that require attentional control like task-switching, and reward-based tasks like gambling or reversal learning. However, there is a complex relationship between the specific cognitive problems faced by an individual patient, their stage of disease and dopaminergic treatment. We used a bimodality continuous performance task during fMRI to examine how patients with Parkinson's disease represent the prospect of reward and switch between competing task rules accordingly. The task-switch was not separately cued but was based on the implicit reward relevance of spatial and verbal dimensions of successive compound stimuli. Nineteen patients were studied in relative ‘on’ and ‘off’ states, induced by dopaminergic medication withdrawal (Hoehn and Yahr stages 1–4). Patients were able to successfully complete the task and establish a bias to one or other dimension in order to gain reward. However the lateral prefrontal cortex and caudate nucleus showed a non-linear U-shape relationship between motor disease severity and regional brain activation. Dopaminergic treatment led to a shift in this U-shape function, supporting the hypothesis of differential neurodegeneration in separate motor and cognitive cortico–striato–thalamo–cortical circuits. In addition, anterior cingulate activation associated with reward expectation declined with more severe disease, whereas activation following actual rewards increased with more severe disease. This may facilitate a change in goal-directed behaviours from deferred predicted rewards to immediate actual rewards, particularly when on dopaminergic treatment. We discuss the implications for investigation and optimal treatment of this common condition at different stages of disease.

Key Words: Parkinson's disease; reward; task-shift; fMRI; dopamine

Received January 27, 2008. Revised May 11, 2008. Accepted May 12, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cereb CortexHome page
D. A. Copland, K. L. McMahon, P. A. Silburn, and G. I. de Zubicaray
Dopaminergic Neuromodulation of Semantic Processing: A 4-T fMRI Study with Levodopa
Cereb Cortex, November 1, 2009; 19(11): 2651 - 2658.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. Bodi, S. Keri, H. Nagy, A. Moustafa, C. E. Myers, N. Daw, G. Dibo, A. Takats, D. Bereczki, and M. A. Gluck
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients
Brain, September 1, 2009; 132(9): 2385 - 2395.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Kelly, G. de Zubicaray, A. Di Martino, D. A. Copland, P. T. Reiss, D. F. Klein, F. X. Castellanos, M. P. Milham, and K. McMahon
L-Dopa Modulates Functional Connectivity in Striatal Cognitive and Motor Networks: A Double-Blind Placebo-Controlled Study
J. Neurosci., June 3, 2009; 29(22): 7364 - 7378.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.